Effect of gemfibrozil on serum levels of prostacyclin and precursor fatty acids in hyperlipidemic patients with Type 2 diabetes
- 1 December 1998
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 42 (3), 149-154
- https://doi.org/10.1016/s0168-8227(98)00107-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- α- and β- alkyl-substituted eicosapentaenoic acids: Incorporation into phospholipids and effets on prostaglandin H synthase and 5-lipoxygenaseBiochemical Pharmacology, 1998
- Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression.Proceedings of the National Academy of Sciences, 1996
- Effect of diabetic sera on the conversion of eicosapentaenoic acid (EPA) to prostaglandin I3 by cultured bovine aortic endothelial cellsProstaglandins, 1995
- Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart diseaseProstaglandins, Leukotrienes & Essential Fatty Acids, 1995
- Fibrates modify rat hepatic fatty acid chain elongation and desaturation in vitroBiochemical Pharmacology, 1993
- Gemfibrozil modifies acyl composition of liver microsomal phospholipids from guinea-pigs without promoting peroxisomal proliferationBiochemical Pharmacology, 1993
- Prostacyclin release from the human saphenous vein in diabetics is lower than in nondiabeticsWorld Journal of Surgery, 1992
- Reevaluation of circulating prostacyclin and thromboxane in diabetesProstaglandins, Leukotrienes and Medicine, 1987
- New water-soluble hydrogen donors for the enzymatic photometric determination of hydrogen peroxide. II. N-ethyl-N-(2-hydroxy-3-sulfopropyl)aniline derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatographyMetabolism, 1978